 |
|
 |
 |
 |
| Company Background |
Markets > Corporate Information > Company Background |
 |
|
|
| ERIS Lifesciences Ltd |
Industry: Pharmaceuticals - Indian - Formulations |
|
|
| BSE Code |
ISIN Demat |
Book Value (R) |
NSE Symbol |
Div Yield % |
Market Cap (Rs.Cr) |
P/E (TTM) |
EPS (TTM) |
Face Value (R) |
| 540596 |
INE406M01024 |
203.3941378 |
ERIS |
0.46 |
21,607.40 |
76.67 |
20.69 |
1 |
|
|
|
|
| Incorporation Year |
2007 |
| Registered Office |
8th Floor Commerce House -IV,Prahladnagar 100 FT Road, Ahmedabad, Gujarat-380015 |
| Telephone |
91-79-30451000 |
| Fax |
91-79-48903474 |
| Chairman |
Amit Indubhushan Bakshi |
| Managing Director |
Amit Indubhushan Bakshi |
| Company Secretary |
Milind Talegaonkar |
| Auditor |
Deloitte Haskins & Sells LLP |
| Face Value |
1 |
| Market Lot |
1 |
| Listing |
BSE,NSE |
| Registrar |
MUFG Intime India Pvt Ltd C-101 247 Park,L B S Marg,Vikhroli West,Mumbai-400083 |
|
|
|
|
|
 |
|
|
|
|
|
|
|